53 related articles for article (PubMed ID: 15176917)
1. Effects of topiramate in adults with Prader-Willi syndrome.
Shapira NA; Lessig MC; Lewis MH; Goodman WK; Driscoll DJ
Am J Ment Retard; 2004 Jul; 109(4):301-9. PubMed ID: 15176917
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of body image by persons with Prader-Willi syndrome and their parents.
Napolitano DA; Zarcone J; Nielsen S; Wang H; Caliendo JM
Am J Intellect Dev Disabil; 2010 Jan; 115(1):43-53. PubMed ID: 20025358
[TBL] [Abstract][Full Text] [Related]
3. Topiramate's reduction of body mass index in heavy drinkers: lack of moderation by a GRIK1 polymorphism.
Kranzler HR; Feinn R; Gelernter J; Pond T; Covault J
Exp Clin Psychopharmacol; 2014 Oct; 22(5):419-23. PubMed ID: 24978347
[TBL] [Abstract][Full Text] [Related]
4. Prader-Willi syndrome: Symptoms and topiramate response in light of genetics.
Louveau C; Turtuluci MC; Consoli A; Poitou C; Coupaye M; Krebs MO; Chaumette B; Iftimovici A
Front Neurosci; 2023; 17():1126970. PubMed ID: 36814790
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole treatment for temper outbursts in Prader-Willi syndrome.
Deest M; Wieting J; Jakob MM; Deest-Gaubatz S; Groh A; Seifert J; Toto S; Bleich S; Frieling H; Eberlein CK
Orphanet J Rare Dis; 2022 Aug; 17(1):324. PubMed ID: 36028863
[TBL] [Abstract][Full Text] [Related]
6. Anti-Obesity Medication Use in Children and Adolescents with Prader-Willi Syndrome: Case Review and Literature Search.
Goldman VE; Naguib MN; Vidmar AP
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640558
[TBL] [Abstract][Full Text] [Related]
7. Skin Picking in People with Prader-Willi Syndrome: Phenomenology and Management.
Bull LE; Oliver C; Woodcock KA
J Autism Dev Disord; 2021 Jan; 51(1):286-297. PubMed ID: 32495267
[TBL] [Abstract][Full Text] [Related]
8. Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study.
Consoli A; Çabal Berthoumieu S; Raffin M; Thuilleaux D; Poitou C; Coupaye M; Pinto G; Lebbah S; Zahr N; Tauber M; Cohen D; Bonnot O
Transl Psychiatry; 2019 Nov; 9(1):274. PubMed ID: 31685813
[TBL] [Abstract][Full Text] [Related]
9. Management of Self-injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview.
Sabus A; Feinstein J; Romani P; Goldson E; Blackmer A
Pharmacotherapy; 2019 Jun; 39(6):645-664. PubMed ID: 30793794
[TBL] [Abstract][Full Text] [Related]
10. A multidisciplinary approach to the clinical management of Prader-Willi syndrome.
Duis J; van Wattum PJ; Scheimann A; Salehi P; Brokamp E; Fairbrother L; Childers A; Shelton AR; Bingham NC; Shoemaker AH; Miller JL
Mol Genet Genomic Med; 2019 Mar; 7(3):e514. PubMed ID: 30697974
[TBL] [Abstract][Full Text] [Related]
11. Obesity management in Prader-Willi syndrome: current perspectives.
Crinò A; Fintini D; Bocchini S; Grugni G
Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
[TBL] [Abstract][Full Text] [Related]
12. Topiramate in the treatment of Prader-Willi syndrome: A case report.
East N; Maroney M
Ment Health Clin; 2017 Jan; 7(1):7-9. PubMed ID: 29955490
[TBL] [Abstract][Full Text] [Related]
13. The Developmental Trajectory of Self-Injurious Behaviours in Individuals with Prader Willi Syndrome, Autism Spectrum Disorder and Intellectual Disability.
Rice LJ; Gray KM; Howlin P; Taffe J; Tonge BJ; Einfeld SL
Diseases; 2016 Feb; 4(1):. PubMed ID: 28933389
[TBL] [Abstract][Full Text] [Related]
14. Certainty of genuine treatment increases drug responses among intellectually disabled patients.
Jensen KB; Kirsch I; Pontén M; Rosén A; Yang K; Gollub RL; des Portes V; Kaptchuk TJ; Curie A
Neurology; 2017 May; 88(20):1912-1918. PubMed ID: 28424273
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.
Bonnot O; Cohen D; Thuilleaux D; Consoli A; Cabal S; Tauber M
Eur J Pediatr; 2016 Jan; 175(1):9-18. PubMed ID: 26584571
[TBL] [Abstract][Full Text] [Related]
16. Prader-willi syndrome: clinical aspects.
Elena G; Bruna C; Benedetta M; Stefania DC; Giuseppe C
J Obes; 2012; 2012():473941. PubMed ID: 23133744
[TBL] [Abstract][Full Text] [Related]
17. An open-label trial of topiramate in the treatment of skin picking in pervasive developmental disorder not otherwise specified.
Jafferany M; Shireen F; Ibrahim A
Prim Care Companion J Clin Psychiatry; 2010; 12(2):. PubMed ID: 20694122
[No Abstract] [Full Text] [Related]
18. Clinical management of behavioral characteristics of Prader-Willi syndrome.
Ho AY; Dimitropoulos A
Neuropsychiatr Dis Treat; 2010 May; 6():107-18. PubMed ID: 20505842
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
